Suppr超能文献

环形闭合装置预防复发性腰椎间盘突出症的有效性:5 年随访的二次分析。

Effectiveness of an Annular Closure Device to Prevent Recurrent Lumbar Disc Herniation: A Secondary Analysis With 5 Years of Follow-up.

机构信息

Department of Neurosurgery, Medical University Innsbruck, Innsbruck, Austria.

Department of Neurosurgery, Donauisar Klinikum Deggendorf, Deggendorf, Germany.

出版信息

JAMA Netw Open. 2021 Dec 1;4(12):e2136809. doi: 10.1001/jamanetworkopen.2021.36809.

Abstract

IMPORTANCE

Patients with large annular defects following lumbar microdiscectomy for disc herniation are at increased risk for symptomatic recurrence and reoperation.

OBJECTIVE

To determine whether a bone-anchored annular closure device in addition to lumbar microdiscectomy resulted in lower reherniation and reoperation rates vs lumbar microdiscectomy alone.

DESIGN, SETTING, AND PARTICIPANTS: This secondary analysis of a multicenter randomized clinical trial reports 5-year follow-up for enrolled patients between December 2010 and October 2014 at 21 clinical sites. Patients in this study had a large annular defect (6-10 mm width) following lumbar microdiscectomy for treatment of lumbar disc herniation. Statistical analysis was performed from November to December 2020.

INTERVENTIONS

Lumbar microdiscectomy with additional bone-anchored annular closure device (device group) or lumbar microdiscectomy only (control group).

MAIN OUTCOMES AND MEASURES

The incidence of symptomatic reherniation, reoperation, and adverse events as well as changes in leg pain, Oswestry Disability Index, and health-related quality of life when comparing the device and control groups over 5 years of follow-up.

RESULTS

Among 554 randomized participants (mean [SD] age: 43 [11] years; 327 [59%] were men), 550 were included in the modified intent-to-treat efficacy population (device group: n = 272; 270 [99%] were White); control group: n = 278; 273 [98%] were White) and 550 were included in the as-treated safety population (device group: n = 267; control group: n = 283). The risk of symptomatic reherniation (18.8% [SE, 2.5%] vs 31.6% [SE, 2.9%]; P < .001) and reoperation (16.0% [SE, 2.3%] vs 22.6% [SE, 2.6%]; P = .03) was lower in the device group. There were 53 reoperations in 40 patients in the device group and 82 reoperations in 58 patients in the control group. Scores for leg pain severity, Oswestry Disability Index, and health-related quality of life significantly improved over 5 years of follow-up with no clinically relevant differences between groups. The frequency of serious adverse events was comparable between the treatment groups. Serious adverse events associated with the device or procedure were less frequent in the device group (12.0% vs 20.5%; difference, -8.5%; 95% CI, -14.6% to -2.3%; P = .008).

CONCLUSIONS AND RELEVANCE

In patients who are at high risk of recurrent herniation following lumbar microdiscectomy owing to a large defect in the annulus fibrosus, this study's findings suggest that annular closure with a bone-anchored implant lowers the risk of symptomatic recurrence and reoperation over 5 years of follow-up.

TRIAL REGISTRATION

ClinicalTrials.gov Identifier: NCT01283438.

摘要

重要性

对于因椎间盘突出症接受腰椎显微切除术而出现大环形缺损的患者,症状复发和再次手术的风险增加。

目的

确定在腰椎显微切除术后附加骨锚定环形封闭装置是否比单纯腰椎显微切除术导致更低的再突出和再手术率。

设计、地点和参与者:这是一项多中心随机临床试验的二次分析,报告了 2010 年 12 月至 2014 年 10 月在 21 个临床站点入组患者的 5 年随访情况。本研究中的患者在因腰椎间盘突出症接受腰椎显微切除术治疗后存在大环形缺损(6-10mm 宽)。统计分析于 2020 年 11 月至 12 月进行。

干预措施

附加骨锚定环形封闭装置的腰椎显微切除术(装置组)或单纯腰椎显微切除术(对照组)。

主要结局和测量指标

在 5 年随访期间,比较装置组和对照组的症状性再突出、再次手术和不良事件的发生率,以及腿部疼痛、Oswestry 残疾指数和健康相关生活质量的变化。

结果

在 554 名随机参与者中(平均[标准差]年龄:43[11]岁;327[59%]为男性),550 名被纳入改良意向治疗疗效人群(装置组:n=272;270[99%]为白人);对照组:n=278;273[98%]为白人)和 550 名被纳入实际治疗安全性人群(装置组:n=267;对照组:n=283)。在装置组中,症状性再突出(18.8%[SE,2.5%] vs 31.6%[SE,2.9%];P<.001)和再次手术(16.0%[SE,2.3%] vs 22.6%[SE,2.6%];P=0.03)的风险较低。在装置组中,有 40 名患者中有 53 次再手术,58 名患者中有 82 次再手术。在 5 年随访期间,腿部疼痛严重程度、Oswestry 残疾指数和健康相关生活质量评分显著改善,两组之间无临床相关差异。两组之间严重不良事件的发生频率相当。装置组的严重不良事件与装置或手术相关的频率较低(12.0% vs 20.5%;差异,-8.5%;95%CI,-14.6%至-2.3%;P=0.008)。

结论和相关性

对于因纤维环大缺陷而在腰椎显微切除术后有复发性突出高风险的患者,本研究结果表明,环形封闭装置降低了 5 年随访期间症状复发和再次手术的风险。

试验注册

ClinicalTrials.gov 标识符:NCT01283438。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3493/8662371/fc4f951a0440/jamanetwopen-e2136809-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验